Peter Steele

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Assembly and Dynamics of Myofibrils

Pathological considerations in replacement cardiac valves

Pharmacology and Management of the Vitamin K Antagonists

Mechanisms of Thrombus Formation

Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years

Thrombotic and Bleeding Complications of Prosthetic Heart Valves

Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry

Oral Anticoagulant Therapy

Omega-3 fatty acids in health and disease and in growth and development

Cushing's syndrome

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

Exercise Standards for Testing and Training

Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect

2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults

Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines

Primary Pulmonary Hypertension

Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention

Sustained-Release Diltiazem Reduces Myocardial Ischemic Episodes in End-Stage Renal Disease

Human Vascular Smooth Muscle Cells Undergo Vesicle-Mediated Calcification in Response to Changes in Extracellular Calcium and Phosphate Concentrations

Regulatory Functions of the Vascular Endothelium

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic

A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

The Pharmacology and Management of the Vitamin K Antagonists

Pulmonary thrombosis in adults with Eisenmenger syndrome

Massive Neonatal Adrenal Enlargement Due to Cytomegaly, Persistence of the Transient Cortex, and Hyperplasia of the Permanent Cortex

TRPM7, the Mg2+ Inhibited Channel and Kinase

Expert consensus document on arterial stiffness: methodological issues and clinical applications

Hemorrhagic Complications of Anticoagulant Treatment

The importance of the ratio of omega-6/omega-3 essential fatty acids

Role of YAP/TAZ in mechanotransduction

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

Coexistent pulmonary and portal hypertension: Morphologic and clinical features

Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness

Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult

Guidelines for clinical use of cardiac radionuclide imaging report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Radionuclide Imaging), developed in collaboration with the American Society of Nuclear Cardiology

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

A contractile and counterbalancing adhesion system controls the 3D shape of crawling cells

Magnesium in Man: Implications for Health and Disease

Monitoring of the Burn Patient

Mechanical control of tissue and organ development

Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets

Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location.

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)

Volume-dependent effects of positive airway pressure on intracavitary left ventricular end-diastolic pressure.

Late results of coronary artery grafting: Is there a flag on the field?

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

The effect of diltiazem on mortality and reinfarction after myocardial infarction

Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves

Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.

Bioceramics

Blood pressure, stroke, and coronary heart disease

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

Late results of coronary artery grafting: Is there a flag on the field?: Reply

2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Burn Wound Infections

Increased in vivo and in vitro platelet function in type II- and type IV-hyperlipoproteinemia

Third-Generation Biomedical Materials

Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement

A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

The biology of platelet-derived growth factor

ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Platelet activation by plasma lipoproteins

Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives

Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.

Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise

Nifedipine

Vessel injury, platelet adherence, and platelet survival.

Adrenal Cytomegaly: Quantitative Assessment by Image Analysis

Cellular nonmuscle myosins NMHC‐IIA and NMHC‐IIB and vertebrate heart looping

Thallium-201 myocardial imaging during maximal and submaximal exercise: Comparison of submaximal exercise with propranolol

Platelet survival time in patients with hypoxemia and pulmonary hypertension.

Platelet survival time following aortic valve replacement.

Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.

Effect of Platelet Suppressant Treatment with Dipyridamole and Aspirin on Exercise Performance and Platelet Survival Time in Coronary Disease

Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs.

Efficacy of diltiazem in angina on effort: A multicenter trial

Effects of dietary and pharmacologic alteration of serum lipids on platelet survival time.

Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts.

Positive end-expiratory pressure shifts left ventricular diastolic pressure-area curves